MedPath

Serap Yavuz

🇨🇭Switzerland
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

1

Active:1
Completed:0

Trial Phases

0 Phases

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Evaluation of the Efficacy and Safety of Molnupiravir Treatment in Mild/Moderate Covid-19 Patients.

Active, not recruiting
Conditions
COVID-19
SARS-CoV-2 Infection
Interventions
Drug: Molnupiravir
First Posted Date
2024-01-25
Last Posted Date
2024-01-25
Lead Sponsor
Serap Yavuz
Target Recruit Count
2600
Registration Number
NCT06223932
Locations
🇹🇷

Istanbul University, Istanbul Faculty of Medicine, Department of Infectious Disease, Istanbul, Fatih, Turkey

🇹🇷

Cerrahpasa Faculty of Medicine Infectious Disease Departament, Istanbul, Fatih, Turkey

🇹🇷

Ankara City Hospital, Ankara, Turkey

and more 5 locations

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.